{"database": "lobbying", "table": "lobbying_activities", "rows": [[3430029, "4a86e152-8191-4488-9c71-6301fb5e13f7", "Q3", "AEGIS LLC", 401108688, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA", 2025, "third_quarter", "PHA", "Pharmacy Benefit Manager (PBM) issues and reform. 340B. IRA implementation. H.R.1492: Ensuring Pathways to Innovative Cures (EPIC) Act. Drug pricing. Most-Favored Nation (MFN) International reference pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542 - DRUG Act. H.R.830 - HELP Copays Act.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2025-10-10T11:23:57-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3430029"], "units": {}, "query_ms": 56.16086896043271, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}